Trial
NCT02343575
Valproic Acid for Treatment of Hyperactive or Mixed Delirium in ICU
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Stanford University
Collaborators
—
Condition
Hyperactive Delirium
Intervention
Valproic Acid
Why stopped
We did not recruit the research assistant and terminated the study
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-06-26